Breast Cancer Survivorship

This book discusses the impact on women of the diagnosis and treatment of early breast cancer. Readers will learn about the risks of breast cancer recurrence and interventions to reduce these, such as endocrine therapy and bisphosphonate therapy, as well as the role of lifestyle factors such as diet and exercise. The long-term effects of treatment on fertility, the heart and other systems are discussed, as well the  psychological burden for women who are increasingly likely to be cured from their cancer.  Each chapter provides background and a  practical guide in the management of women after the initial phase of diagnosis and treatment.

Authored by a multidisciplinary team this book provides all the relevant expertise as well as different perspectives, providing a holistic picture of early breast cancer consequences.

From oncologists to general practitioners as well as specialist nurses, gynaecologists, psychologists and other healthcare professionals  involved in the long-term care of women with breast cancer, this book provides a timely and indispensable guide to practitioners caring for early breast cancer survivors.

Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital.

He has a specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a study which will investigate the role of aspirin in the treatment of over 3000 women with early breast cancer. He is Chair of the Committee for Clinical Research at the Royal Marsden Hospital and Institute of Cancer Research. Dr Ring has published widely in peer-reviewed journals and in 2015 edited the textbook “Problem-solving in older cancer patients.”

He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology. 

Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London. 

Dr Parton is Lead Cancer Clinician in The Royal Marsden'sfirst satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support. She has chaired and taken part in groups within  the London Cancer Alliance for the Breast pathway, Chemotherapy Closer to Home, Menopausal Symptoms Management and Sexuality and Consequences of Therapy. She has led on a number of projects delivering care closer to home, and the development of Acute Oncology at cancer centres and cancer units. Dr Parton has been PI to a  number of national and international studies in early breast cancer, and has published in peer-reviewed international journals. 

<